180 related articles for article (PubMed ID: 8026711)
41. Development and validation of a gas chromatographic-mass spectrometric method for simultaneous identification and quantification of marker compounds including bilobalide, ginkgolides and flavonoids in Ginkgo biloba L. extract and pharmaceutical preparations.
Deng F; Zito SW
J Chromatogr A; 2003 Jan; 986(1):121-7. PubMed ID: 12585329
[TBL] [Abstract][Full Text] [Related]
42. In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides.
Amri H; Ogwuegbu SO; Boujrad N; Drieu K; Papadopoulos V
Endocrinology; 1996 Dec; 137(12):5707-18. PubMed ID: 8940403
[TBL] [Abstract][Full Text] [Related]
43. Effects of bilobalide, a sesquiterpene in Ginkgo biloba leaves, on population spikes in rat hippocampal slices.
Sasaki K; Oota I; Wada K; Inomata K; Ohshika H; Haga M
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1999 Nov; 124(3):315-21. PubMed ID: 10661725
[TBL] [Abstract][Full Text] [Related]
44. Chemical analysis, pharmacological activity and process optimization of the proportion of bilobalide and ginkgolides in Ginkgo biloba extract.
Xiaoyan L; Li C; Liu T; Ke H; Gong X; Wang Q; Zhang J; Fan X
J Pharm Biomed Anal; 2018 Oct; 160():46-54. PubMed ID: 30071391
[TBL] [Abstract][Full Text] [Related]
45. Rapid analysis of terpene lactones in extract of Ginkgo biloba L. by high performance liquid chromatography.
Wang HF; Ju XR
Se Pu; 2000 Sep; 18(5):394-7. PubMed ID: 12541697
[TBL] [Abstract][Full Text] [Related]
46. Induction of cytochrome P450 3A by the Ginkgo biloba extract and bilobalides in human and rat primary hepatocytes.
Deng Y; Bi HC; Zhao LZ; Wang XD; Chen J; Ou ZM; Ding L; Xu LJ; Guan S; Chen X; Zhou SF; Huang M
Drug Metab Lett; 2008 Jan; 2(1):60-6. PubMed ID: 19356072
[TBL] [Abstract][Full Text] [Related]
47. Enhanced anti-amnestic effect of donepezil by Ginkgo biloba extract (EGb 761) via further improvement in pro-cholinergic and antioxidative activities.
Zhao J; Li K; Wang Y; Li D; Wang Q; Xie S; Wang J; Zuo Z
J Ethnopharmacol; 2021 Apr; 269():113711. PubMed ID: 33352242
[TBL] [Abstract][Full Text] [Related]
48. Bilobalide in Ginkgo biloba extract is a major substance inducing hepatic CYPs.
Umegaki K; Taki Y; Endoh K; Taku K; Tanabe H; Shinozuka K; Sugiyama T
J Pharm Pharmacol; 2007 Jun; 59(6):871-7. PubMed ID: 17637180
[TBL] [Abstract][Full Text] [Related]
49. Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant alpha1beta2gamma2L GABA(A) receptors.
Huang SH; Duke RK; Chebib M; Sasaki K; Wada K; Johnston GA
Eur J Pharmacol; 2003 Mar; 464(1):1-8. PubMed ID: 12600688
[TBL] [Abstract][Full Text] [Related]
50. Isolation of ginkgolides A, B, C, J and bilobalide from G. biloba extracts.
Jaracz S; Malik S; Nakanishi K
Phytochemistry; 2004 Nov; 65(21):2897-902. PubMed ID: 15501258
[TBL] [Abstract][Full Text] [Related]
51. The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex.
Yoshitake T; Yoshitake S; Kehr J
Br J Pharmacol; 2010 Feb; 159(3):659-68. PubMed ID: 20105177
[TBL] [Abstract][Full Text] [Related]
52. Quantitative analysis of bilobalide and ginkgolides from Ginkgo biloba leaves and Ginkgo products using (1)H-NMR.
Choi YH; Choi HK; Hazekamp A; Bermejo P; Schilder Y; Erkelens C; Verpoorte R
Chem Pharm Bull (Tokyo); 2003 Feb; 51(2):158-61. PubMed ID: 12576648
[TBL] [Abstract][Full Text] [Related]
53. Adrenalectomy-induced cell death in the dentate gyrus: further characterisation using TUNEL and effects of the Ginkgo biloba extract, EGb 761, and ginkgolide B.
Maclennan KM; Zheng Y; Sheard PW; Williams SM; Darlington CL; Smith PF
Hippocampus; 2003; 13(2):212-25. PubMed ID: 12699329
[TBL] [Abstract][Full Text] [Related]
54. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus.
Kudolo GB
J Clin Pharmacol; 2001 Jun; 41(6):600-11. PubMed ID: 11402628
[TBL] [Abstract][Full Text] [Related]
55. Age-related changes in the vasodilating actions of Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta.
Nishida S; Satoh H
Clin Chim Acta; 2005 Apr; 354(1-2):141-6. PubMed ID: 15748610
[TBL] [Abstract][Full Text] [Related]
56. Human pregnane X receptor agonism by Ginkgo biloba extract: assessment of the role of individual ginkgolides.
Lau AJ; Yang G; Rajaraman G; Baucom CC; Chang TK
J Pharmacol Exp Ther; 2010 Dec; 335(3):771-80. PubMed ID: 20739453
[TBL] [Abstract][Full Text] [Related]
57. Mechanisms for the vasodilations induced by Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta.
Nishida S; Satoh H
Life Sci; 2003 Apr; 72(23):2659-67. PubMed ID: 12672511
[TBL] [Abstract][Full Text] [Related]
58. Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii.
Atzori C; Bruno A; Chichino G; Bombardelli E; Scaglia M; Ghione M
Antimicrob Agents Chemother; 1993 Jul; 37(7):1492-6. PubMed ID: 8363381
[TBL] [Abstract][Full Text] [Related]
59. Bilobalide and neuroprotection.
Defeudis FV
Pharmacol Res; 2002 Dec; 46(6):565-8. PubMed ID: 12457632
[TBL] [Abstract][Full Text] [Related]
60. Liquid chromatography-atmospheric pressure chemical ionisation/mass spectrometry: a rapid and selective method for the quantitative determination of ginkgolides and bilobalide in ginkgo leaf extracts and phytopharmaceuticals.
Jensen AG; Ndjoko K; Wolfender JL; Hostettmann K; Camponovo F; Soldati F
Phytochem Anal; 2002; 13(1):31-8. PubMed ID: 11899603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
